| vit D | Vitamin D |
| 25(OH)D | Calcidiol, 25 hydroxycholecalciferol or 25-hidroxivitamin D |
| 1,25(OH)2D3 | 1,25-Dihydroxyvitamin D3 |
| DBP | Vitamin D-binding protein |
| CYP2R1 | Vitamin D 25-hydroxylase or cytochrome P450 2R1 |
| CYP27B1 | 1-α-Hydroxylase (1α-hydroxylase) |
| CYP24A1 | Cytochrome P450 family 24 subfamily A member 1 |
| FGF-23 | Fibroblast growth factor 23 |
| PTH | Parathyroid hormone |
| TNFα | Tumour necrosis factor α |
| IFNγ | Interferon gamma |
| UV | Ultra violet |
| VDR | Vitamin D receptor |
| RXR | Retinoid-X-receptor |
| VDRE | Vitamin D responsive elements |
| HAT | Histone acetyl transferases |
| NCoR | Nuclear receptor corepressor |
| SMRT NFAT |
Retinoid or thyroid-hormone receptors Nuclear factor of activated T-cells |
| TSH | Thyroid-stimulating hormone |
| TRH | Thyrotropin-releasing hormone |
| TLR | Toll like receptor |
| NF-κB | Nuclear factor α B |
| DC | Dendritic cells |
| M-DCs | Myeloid dendritic cells |
| P-DCs | Plasmacytoid dendritic cells |
| MR | Manose receptors |
| CAMP | Cathelicidin |
| DEFB4 | β defensin 2 |
| CCR10 | C-C chemokine receptor type 10 |
| NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 |
| SINE | Introduction of a nuclear element |
| PAMPs | Molecular patterns associated with pathogen surveillance |
| PRRs | Pattern recognition receptors |
| MDR | Multidrug resistance |
| HAMP | Hepcidin antimicrobial peptide |
| CFU-GM | Granulocyte macrophage colony forming cell |
| RAR | Retinoic acid receptor |
| RXR | Retinoid X receptor |
| SRC | Steroid receptor coactivator |
| DRIP | Vitamin D receptor interacting protein |
| PKC | Protein kinase C |
| MAPK | Mitogen activated kinase |
| iNKT | Invariant natural killer T cells |
| HSPC | Hematopoietic stem progenitor cell |
| HSC | Hematopoiectic stem cell |
| MDS | Myelodysplastic syndromes |
| AML | Acute myeloblastic leukaemias |
| ATRA | All-trans retinoic acid |
| APL | Acute promyelocytic leukaemia |
| EFS | Event free survival |
| AZA | 5-Azacytidine |
| HR | Hazard ratio |
| CI | Confidence interval |
| OS | Overall survival |
| HSCT | Hematopoietic stem cell transplantation |
| CMV | Cytomegalovirus |
| cGVHD | Chronic graft-versus-host disease |
| aGVHD | Acute graft-versus-host disease |